Pharmaceutical Solutions
Showing 51 - 75 of 3,362
Ocular Redness Trial in United States (Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation, Lumify®
Recruiting
- Ocular Redness
- Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation
- Lumify® (brimonidine tartrate ophthalmic solution 0.025%)
-
Colorado Springs, Colorado
- +5 more
Oct 3, 2022
Dry Eye Trial in Fort Worth (Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF), Polyethylene
Not yet recruiting
- Dry Eye
- Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF)
- Polyethylene glycol 400 and propylene glycol solution/drops - Preserved
-
Fort Worth, TexasAlcon Call Center for Trial Locations
Jul 6, 2023
Contact Allergy Trial (Rubber accelerators and control chamber/solution for NON-SLS group, SLS, Rubber accelerators and control
Not yet recruiting
- Contact Allergy
- Rubber accelerators and control chamber/solution for NON-SLS group
- +3 more
- (no location specified)
Sep 11, 2023
Cardiac Surgery Trial in Lund (Heart-lung machine primining solution which includes Mannitol, Heart-lung machine primining
Completed
- Cardiac Surgery
- Heart-lung machine primining solution which includes Mannitol
- Heart-lung machine primining solution which does not include Mannitol
-
Lund, Skane, SwedenThorax
Jan 14, 2022
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, Latanoprost ophthalmic
Recruiting
- Primary Open Angle Glaucoma, Ocular Hypertension
- STN1012600 ophthalmic solution 0.002%
- Latanoprost ophthalmic solution 0.005%
-
Aichi, Japan
- +42 more
Aug 9, 2022
Ocular Discomfort in Glaucoma Patients Using Multiple Topical
Recruiting
- Glaucoma
- Ocular Surface Disease
- Xiidra (Lifitegrast ophthalmic solution) 5%
-
Fountain Valley, CaliforniaDoheny Eye Center UCLA
Oct 31, 2022
Dry Eye Trial in Raynham (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)
Completed
- Dry Eye
- Reproxalap Ophthalmic Solution (0.25%)
- Vehicle Ophthalmic Solution
-
Raynham, MassachusettsAndover Eye Associates (Raynham)
Aug 2, 2022
Postoperative Sore Throat Trial in Shibin Al Kawm (internal superior laryngeal nerve block, Lidocaine 2% Injectable Solution,
Recruiting
- Postoperative Sore Throat
- internal superior laryngeal nerve block
- +2 more
-
Shibīn Al Kawm, Menoufia, EgyptMenoufia University Hospitals
Apr 11, 2023
Respiratory Syncytial Virus Infections Trial in Changsha (XW001, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- XW001
- Placebo
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 30, 2022
Normal Tension Glaucoma, Low-Tension Glaucoma, Bilateral, Low-Tension Glaucoma, Unspecified Eye Trial in Seoul, Manila (QLS-111
Not yet recruiting
- Normal Tension Glaucoma
- +3 more
- QLS-111 ophthalmic solution, (0.015%)
- +2 more
-
Seoul, Korea, Republic of
- +1 more
Sep 6, 2023
Osteoarthritis, Hyperthyroidism, Iodine Toxicity Trial in Ankara (PI solution, Saline Solution)
Recruiting
- Osteoarthritis
- +2 more
- PI solution
- Saline Solution
-
Ankara, TurkeyAnkara University Faculty of Medicine
Oct 26, 2022
Myopia Trial in United States (Atropine 0.1% Ophthalmic Solution, Atropine 0.01% Ophthalmic Solution, Placebo Ophthalmic
Recruiting
- Myopia
- Atropine 0.1% Ophthalmic Solution
- +2 more
-
Birmingham, Alabama
- +18 more
Dec 14, 2021
Diabetes, Type 2 Trial in United States (Gan & Lee Insulin Glargine Injection, Lantus®)
Completed
- Diabetes Mellitus, Type 2
- Gan & Lee Insulin Glargine Injection
- Lantus®
-
Birmingham, Alabama
- +56 more
Mar 23, 2022
Diagnostic Gastroscopy Trial (Lidocaine 2% Injectable Solution, Saline administration as , Propofol injection)
Not yet recruiting
- Diagnostic Gastroscopy
- Lidocaine 2% Injectable Solution
- +3 more
- (no location specified)
Nov 23, 2023
Septic Shock, Shock Trial in India (Balanced crystalloid solution, 0.9%sodium chloride)
Completed
- Septic Shock
- Shock
- Balanced crystalloid solution
- 0.9%sodium chloride
-
New Delhi, Delhi, India
- +3 more
Dec 6, 2021
Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,
Not yet recruiting
- Allergic Conjunctivitis
- Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
- +3 more
-
Phoenix, Arizona
- +2 more
Nov 9, 2022
Erector Spinae Plane Block Trial in Cairo (Use Bupivacaine 0.25% Injectable Solution, Bupivacaine 0.25% Injectable Solution plus
Recruiting
- Erector Spinae Plane Block
- Use Bupivacaine 0.25% Injectable Solution
- Bupivacaine 0.25% Injectable Solution plus Dexmedetomidine
-
Cairo, EgyptFaculty of Medicine Ain Shams University
Aug 31, 2023
Healthy Trial (Tramadol Hydrochloride 5 MG/ML Oral Solution, Tramadol Hydrochloride 100 MG/ML Oral Solution (Contramal(r)))
Not yet recruiting
- Healthy
- Tramadol Hydrochloride 5 MG/ML Oral Solution
- Tramadol Hydrochloride 100 MG/ML Oral Solution (Contramal(r))
- (no location specified)
Feb 6, 2023
Acute Gouty Arthritis Trial in United States (Anakinra 100 mg, Triamcinolone Acetonide 40 mg, Placebo to Anakinra 100 mg)
Completed
- Acute Gouty Arthritis
- Anakinra 100 mg
- +3 more
-
Birmingham, Alabama
- +36 more
Jul 1, 2020
Food Preferences, Appetitive Behavior Trial (Conditioned Stimulus: Sucrose (aim 1), Conditioned Stimulus: Glucose (aim 1),
Not yet recruiting
- Food Preferences
- Appetitive Behavior
- Conditioned Stimulus: Sucrose (aim 1)
- +5 more
- (no location specified)
Aug 24, 2023
ADHD Trial in United States (Dasotraline, Placebo Comparator)
Completed
- Attention Deficit Hyperactivity Disorder
- Dasotraline
- Placebo Comparator
-
Dothan, Alabama
- +42 more
Mar 16, 2021
Subcutaneous Fat Disorder Trial (10XB-101 Solution for Injection, 6.0%, Placebo Solution for Injection (no active ingredient))
Not yet recruiting
- Subcutaneous Fat Disorder
- 10XB-101 Solution for Injection, 6.0%
- Placebo Solution for Injection (no active ingredient)
- (no location specified)
Feb 27, 2023